Q1 2026 Management View CEO Emily Leproust highlighted "a strong start to fiscal 2026 and extend a pattern of consistent execution, marking our 12th consecutive quarter of revenue growth." She ...

BOULDER — Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round. Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round.

This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership ...

Paine Schwartz Partners–backed HGS BioScience, Jacksonville, Flordia, a leading provider of biological crop solutions, ...

The biotech company posted revenue of $103.7 million for the quarter ended December 31, 2025, surpassing the analyst consensus of $100.72 million and representing a 17% increase from $88.7 million in ...

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.

The Nasdaq-listed company has recurring losses and no revenue.